PsyBio Therapeutics (OTC:PSYBF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does PsyBio Therapeutics (PSYBF) operate in?

PsyBio Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCEM.

PsyBio Therapeutics Stock (OTC: PSYBF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 9.05K
Day Range	- - -
52 Wk Range	0.00 - 0.02
Market Cap	$12.75K
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	43.31

Recent News

MA, FL And OH Psychedelics Scientists And Educators' Latest Research And Views

Along with a growing scientific corpus supporting the therapeutic potential of psychedelics, several states and most noticeably Massachusetts are seeing the decriminalization of natural substances via local measures.

Lara Goldstein

EXCLUSIVE: In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental health conditions and how clinical dat

Joana Scopel

Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More

Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 9.05K
Day Range	- - -
52 Wk Range	0.00 - 0.02
Market Cap	$12.75K
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	43.31

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy PsyBio Therapeutics (PSYBF) stock?

You can purchase shares of PsyBio Therapeutics (OTCEM:PSYBF) through any online brokerage.

View our list of the best stock brokerages

Who are PsyBio Therapeutics (PSYBF) competitors?

There are no as such competitors for PsyBio Therapeutics.

What is the forecast, or price target, for PsyBio Therapeutics (PSYBF) stock?

There is no analysis for PsyBio Therapeutics to provide a consensus price target.

What is the current price for PsyBio Therapeutics (PSYBF)?

The stock price for PsyBio Therapeutics (OTCEM: PSYBF) is $0.115 last updated August 25, 2022 at 4:00 PM EDT.

Does PsyBio Therapeutics (PSYBF) pay a dividend?

There are no upcoming dividends for PsyBio Therapeutics.

When is PsyBio Therapeutics (OTCEM:PSYBF) reporting earnings?

PsyBio Therapeutics does not have any upcoming earnings scheduled.

Is PsyBio Therapeutics (PSYBF) going to split?

There is no upcoming split for PsyBio Therapeutics.

What sector and industry does PsyBio Therapeutics (PSYBF) operate in?

PsyBio Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCEM.

Comments

PsyBio Therapeutics

PsyBio Therapeutics (PSYBF) Forecast